Download Audio
Faculty Disclosures
CME Information
Event
CME Test
banner
  Go to Second Opinion Case 1 (Discussant: Dr Hudis)
Go to Second Opinion Case 2 (Discussant: Dr O’Shaughnessy)
Go to Second Opinion Case 3 (Discussant: Dr Budd)
Go to Second Opinion Case 4 (Discussant: Dr Sledge)
Go to Second Opinion Case 5 (Discussant: Prof Forbes)
Go to Second Opinion Case 6 (Discussant: Dr Sparano)
Go to Second Opinion Case 7 (Discussant: Dr Chlebowski)
 


To listen to individual tracks, click the on the track you wish to listen to.
To download tracks, right-click on the one you wish to download.
   
Hudis, MD Clifford Hudis, MD
Chief, Breast Cancer Medicine Service
Solid Tumor Division
Department of Medicine
Memorial Sloan-Kettering
Cancer Center
New York, New York

Second Opinion Case 1
Topic: First-line systemic therapy for patients with ER-positive, HER2-negative, symptomatic visceral metastases
Click here to listen to the entire debate 1
   
O’Shaughnessy, MD Joyce O’Shaughnessy, MD
Co-Director, Breast Cancer Research
Program, Baylor-Charles A Sammons
Cancer Center, Texas Oncology, PA
US Oncology
Dallas, Texas
Second Opinion Case 2
Topic: Choice of taxane in the management of metastatic disease
Click here to listen to the entire debate 2
   
Budd, MD G Thomas Budd, MD
Professor of Medicine
Cleveland Clinic Lerner
College of Medicine
Cleveland Clinic Foundation
Cleveland, Ohio
Second Opinion Case 3
Topic: New research strategies in the management of ER-positive breast cancer, including combined biologic and endocrine therapy
Click here to listen to the entire debate 3
   
Sledge, MD George W Sledge Jr, MD
Ballve-Lantero Professor of Oncology
Professor of Medicine and Pathology
Melvin and Bren Simon Indiana
University Cancer Center
Indianapolis, Indiana
Second Opinion Case 4
Topic: Adjuvant systemic therapy for subcentimeter, node-negative tumors
Click here to listen to the entire debate 4
   
Forbes, MD John F Forbes, MD
Professor, University of Newcastle
Director, Department of Surgical
Oncology, Calvary Mater
Newcastle Hospital
Newcastle, New South Wales
Australia
Second Opinion Case 5
Topic: Long-term adjuvant endocrine therapy for postmenopausal patients
Click here to listen to the entire debate 5
   
Sparano, MD Joseph A Sparano, MD
Professor of Medicine and Women’s Health, Albert Einstein
College of Medicine; Associate
Chairman, Department of Oncology
Montefiore Medical Center
Director, Breast Evaluation Center
Montefiore-Einstein Cancer Center
Bronx, New York
Second Opinion Case 6
Topic: First-line systemic therapy for patients with ER-positive, HER2-positive metastatic disease
Click here to listen to the entire debate 6
   
Chlebowski, MD, PhD Rowan T Chlebowski, MD, PhD
Professor of Medicine
David Geffen School
of Medicine at UCLA
Chief, Division of Medical Oncology
and Hematology
Harbor-UCLA Medical Center
Torrance, California
Second Opinion Case 7
Topic: Endocrine therapy for premenopausal patients, including those who cease menstruation after adjuvant chemotherapy
Click here to listen to the entire debate 7